Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
325 hedge funds and large institutions have $4.85B invested in Amedisys in 2019 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 96 increasing their positions, 107 reducing their positions, and 28 closing their positions.
186% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 28
24% more capital invested
Capital invested by funds: $3.9B → $4.85B (+$946M)
15% more funds holding
Funds holding: 283 → 325 (+42)
2.65% less ownership
Funds ownership: 92.63% → 89.97% (-2.7%)
10% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 107
50% less call options, than puts
Call options by funds: $24.4M | Put options by funds: $48.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$48.9M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$26.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$18.5M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$12.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$84.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$43.9M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$22.4M |
| 4 |
Bank of New York Mellon
New York
|
-$20.9M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$20.3M |
AMED Hedge Fund Activity: Q4 2019 in Review
325 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2019, worth a combined $4.85B — up 24% from $3.9B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new AMED positions and 28 closed out — a net gain of 52 holders — while 96 added to existing stakes and 107 trimmed.
The largest buyer was Wells Fargo, adding an estimated $48.9M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $84.6M sold.
- 325 institutional investors held Amedisys (AMED) as of Q4 2019, up from 283 in Q3 2019.
- Funds reported $4.85B of Amedisys stock for Q4 2019, up 24% quarter-over-quarter.
- 80 funds opened new Amedisys positions in Q4 2019 and 28 closed out, a net change of +52 holders.
- The largest Amedisys buyer in Q4 2019 was Wells Fargo, an estimated $48.9M added.
- The largest Amedisys seller in Q4 2019 was Acadian Asset Management, an estimated $84.6M sold.
Based on aggregated 13F filings for Q4 2019.